Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

Clinical trial NCT00135109 · COMPLETED

Trial details

NCT number: NCT00135109
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Neuropathies

Start date: 2004-10-01
Primary completion: 2005-12-01
Enrollment: 654

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.